Autonomix Medical, Inc. Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| AMIX | RMD | |
|---|---|---|
| Market Cap | $4.09 million | $32.93 billion |
| Revenue (TTM) | — | $5.65 billion |
| Net Income (TTM) | $-16,105,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| AMIX | RMD | |
|---|---|---|
| P/E Ratio | — | 21.90 |
| Price / Book | 1.29 | 5.00 |
| Price / Sales | — | 5.82 |
AMIX leads on 1 of 1 valuation factors.
Profitability
| AMIX | RMD | |
|---|---|---|
| Net Margin | — | 26.94% |
| Return on Equity | -509.33% | 23.13% |
RMD leads on 1 of 1 profitability factors.
Dividend
| AMIX | RMD | |
|---|---|---|
| Dividend Yield | — | 1.16% |
| Payout Ratio | — | 25.31 |
AMIX and RMD split the dividend factors evenly.
Risk & Sentiment
| AMIX | RMD | |
|---|---|---|
| Short Interest | 0.80% | 4.04% |
AMIX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMIX overview, AMIX financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.